Peter French
Follow
Get notifications in MyBN when activity occurs.
Peter French
Non-Executive Chair / Mediland Pharm
Most Notable Role
Dr Peter French is a biotechnology executive and scientist with extensive experience as a chief scientific officer, chief executive and director.
He also has experience in commercialising medical innovations with over 40 years of scientific expertise in cell and molecular biology and over 40 peer-reviewed publications across oncology, immunology, microbiology and neuroscience.
Dr French had a successful academic career as principal scientist at the Centre for Immunology, St Vincent’s Hospital and Post-Doctoral Research Scientist at the Children’s Medical Research Foundation. He was awarded the Faculty of Science Alumni Achievement Award for Innovation and Entrepreneurship in 2019 from the University of Sydney, and was named as one of five Innovators of Influence in 2015 by the Australian Academy of Technology and Engineering.
He also has experience in commercialising medical innovations with over 40 years of scientific expertise in cell and molecular biology and over 40 peer-reviewed publications across oncology, immunology, microbiology and neuroscience.
Dr French had a successful academic career as principal scientist at the Centre for Immunology, St Vincent’s Hospital and Post-Doctoral Research Scientist at the Children’s Medical Research Foundation. He was awarded the Faculty of Science Alumni Achievement Award for Innovation and Entrepreneurship in 2019 from the University of Sydney, and was named as one of five Innovators of Influence in 2015 by the Australian Academy of Technology and Engineering.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1257th | Mediland Pharm | -36% | -15% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 1036th |  | Mediland Pharm | $662k |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Strategic Technology Advisor, INOVIQ | 16 Sep 2021 |
| NEW ROLE: Chief Scientist, Fermiscan | 24 Jul 2020 |
| NEW ROLE: Chief Executive, Managing Director, Benitec | 24 Jul 2020 |
| NEW ROLE: Strategic Technology Advisor, Sienna Cancer Diagnostics | 24 Jul 2020 |
| NEW ROLE: Chief Scientific Officer, INOVIQ | 24 Jul 2020 |
